osteoarthritis
OSTEOARTHRITIS

Osteoarthritis is a chronic progressive disease where there is degeneration & loss of articular cartilage that occurs together with new bone formation at the joint surfaces and margins, that causes pain and deformity.

The patient experiences pain, stiffness, decreased movement, inflammation and crepitus.

The pain is usually aggravated by pain and relieved by rest.

Introduction

  • A clinical syndrome of joint pain with different degrees of limitation in function & decreased quality of life
  • Most common form of arthritis
  • May not be secondary to aging & does not automatically progress
  • Process of progressive softening or localizing loss of cartilage accompanied by inadequate metabolic repair
  • Most often occurs in the hands (ends of the fingers & thumb), spine (neck & lower back), knees & hips
  • Classified as primary or secondary based on the cause or major predisposing factor; both have altered cartilage physiology
    • Primary osteoarthritis is the most common with no known cause
    • Secondary osteoarthritis has identifiable etiology but pathologically similar to primary osteoarthritis
      • Common causes are metabolic diseases (eg hemochromatosis, acromegaly), anatomic causes (eg developmental hip dislocation), trauma (joint surgery, intra-articular fractures, ligament or meniscus damage, malunion), or complication of an inflammatory disorder (septic arthritis, ankylosing spondylitis, rheumatoid arthritis & psoriatic arthritis)

Signs and Symptoms

  • Cardinal features of osteoarthritis are pain, stiffness, decreased movement, inflammation, crepitus & absence of systemic signs & symptoms like fever
    • Osteoarthritis pain is usually aggravated by activities & relieved by rest; not common to occur at night or during rest but may be experienced by patients after several hours of using joints, in advanced osteoarthritis & in acute inflammatory flare
    • Stiffness occurs in the morning lasting for a few minutes but <30 minutes, after period of rest, or in the evening which usually resolves within 10 minutes of activity

Risk Factors

Risk Factors

Age

  • >80% of individuals older than 75 years are affected; not common in patients <40 years old unless with history of trauma

Female Gender

  • Higher risk for knee osteoarthritis after menopause for unclear reasons but may be related to hormones, genetics or other undetermined factors

Genetic Predisposition

  • The influence of genetic factor varies in different subsets of osteoarthritis, ranging from 40-70%

Obesity

  • Increases risk for symptomatic & progressive osteoarthritis
    • Increases the risk for knee osteoarthritis due to the increased mechanical stress on the joints & altered joint biomechanics secondary to changes in posture, gait & level of physical activity
    • Increases stiffness in the subchondral bones & facilitates cartilage breakdown

Joint Trauma or Malalignment

  • Results in rapid development of osteoarthritis or starts the process causing symptomatic osteoarthritis later in life
  • Repetitive, high-impact sports are strongly related to joint injury which increases the risk for lower extremity osteoarthritis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 5 days ago

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

Stephen Padilla, 14 Aug 2019
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
4 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.